Remove news stomach-cancer
article thumbnail

Zolbetuximab Is a Promising Therapy for HER2-Negative Gastric Cancer

XTalks

Gastric cancer, which originates in the stomach, ranks among the most common cancers globally. Gastroesophageal junction (GEJ) adenocarcinoma, a cancer originating at the junction where the esophagus meets the stomach, carries low five-year survival rates for metastatic stage patients.

article thumbnail

In the News: April 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Triple-negative breast cancer. First-line bladder cancer. First-line bladder cancer. Third-line stomach cancer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Obesity represents a catastrophic failure of government policy, public health, and medicine

World of DTC Marketing

Obesity and Cancer. Being overweight or having obesity are linked with a higher risk of getting 13 types of cancer. These cancers make up 40% of all cancers diagnosed in the United States each year. Being overweight and having obesity are linked with a higher risk of getting 13 kinds of cancer. Upper stomach.

Medicine 193
article thumbnail

Tips for Making 2021 a Healthier Year

The Pharma Data

Consumer News. 2, 2021 — A New Year’s resolution to take better care of yourself is one you should keep, especially in the era of COVID-19. For cancer prevention, the American Institute for Cancer Research and the American Cancer Society recommend maintaining a healthy weight, staying active and eating a healthy diet.

article thumbnail

Phathom’s Voquenza (Vonoprazan) Gets FDA Nods for H. Pylori and Erosive GERD

XTalks

Voquenza is a novel potassium-competitive acid blocker (PCAB) and in a news release , Phathom said its FDA approval marks the first major innovation to the US erosive GERD market in over 30 years. It can cause erosions in the gastric mucosa caused by acid reflux from the stomach entering the esophagus.

article thumbnail

Enhertu Moves One Step Closer to Giving Gastric Cancer a Gut Punch

The Pharma Data

priority review for the treatment of HER2-positive metastatic gastric – or gastroesophageal junction (GEJ) cancer. Gastric cancer is the fifth most prevalent cancer in the world and is most often diagnosed in the advanced stages when it has already metastasized to other areas of the body.

article thumbnail

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

The Pharma Data

Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, today announced an agreement under which Amgen will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of approximately $1.9